Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Intercept Pharmaceuticals: Regulatory Snub Unsettles Liver Therapy Front-Runner [Seeking Alpha]

Intercept Pharmaceuticals, Inc. (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
Company Research Source: Seeking Alpha
SummaryThe FDA decision has wiped out more than a third of Intercept’s market cap.Yet, the company remains the front runner in the NASH space.The current trading multiple with our revenue forecasts highlights a sizable premium.Another attempt at the FDA approval could subject the stock to significant volatility.Justifying our neutral view on a company seeking a billion-dollar market opportunity.Investment ThesisFormulating the launch plans well ahead of the approval, Intercept Pharmaceuticals, Inc. (ICPTWith the FDA rejection having shaved off more than a third of the company’s market cap, our revenue forecasts with the current trading multiple indicate an attractive premium. Though the company remains the front-runner in NASH space, the illness that has no approved therapies has an uncertain path for FDA approval, subjecting the developers to significant share price volatility. As regulatory uncertainty overshadow the lucrative market opportunity, we remain neutral on the stock until Show less Read more
Impact Snapshot
Event Time:
ICPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ICPT alerts
Opt-in for
ICPT alerts

from News Quantified
Opt-in for
ICPT alerts

from News Quantified